Clinical Trials Logo

Cervical Cancer Stage IB1 clinical trials

View clinical trials related to Cervical Cancer Stage IB1.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04770090 Recruiting - Clinical trials for Cervical Cancer Stage IB1

Research of Circulating Tumor Cells Released During Cervical Cancer Surgery

CTC-COL
Start date: November 17, 2021
Phase: N/A
Study type: Interventional

Cervical cancer is a rare pathology. Recent studies showed that the risk of recurrence is higher for patients treated by coelioscopy in comparison with laparotomy. It could be explained by the spread of circulating tumor cells (CTC) due to tumor mobilization during different steps of the surgery. The primary goal is to evaluate the spread of CTC during surgery on peripheral blood samples. The secondary outcome is to evaluation the disease-free survival at 3 and 5 years postoperatively. 20 patients with early stage cervical (IA1 to IB2) eligible to coelioscopic stadification and laparoscopic surgery will be included.

NCT ID: NCT04370496 Recruiting - Cervical Cancer Clinical Trials

Safety of Minimally Invasive Surgery Using Endoscopic Stapler in Early Stage Cervical Cancer Patients (SOLUTION)

SOLUTION
Start date: July 2, 2020
Phase: N/A
Study type: Interventional

The SOLUTION trial aims to show the efficacy and safety of performing radical hysterectomy by minimally invasive surgery using an endoscopic stapler in patients with cervical cancer stage IB1 (FIGO staging 2009) and thus to prove that minimally invasive surgery is non-inferior to open surgery.